References
- Origa R. Genetic basis, pathophysiology and diagnosis of thalassaemias. In: Porter J, ed. 2021 Guidelines for the Management of Transfusion Dependent (TDT). 4th ed. Cyprus: Thalassaemia International Federation; 2021:20–32.
- Kementerian Kesehatan Republik Indonesia. Strategi Penanggulangan Talasemia Di Indonesia. 2023.
- Badawy SM, Beg U, Liem RI, Chaudhury S, Thompson AA. A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy. Blood Adv. 2021;5(2):570–583. doi:10.1182/bloodadvances.2020002948.
- Angastiniotis M. Lifestyle and quality of life. In: Maggio A, Porter J, eds. 2021 Guidelines for the Management of Transfusion Dependent (TDT). 4th ed. Cyprus: Thalassaemia International Federation; 2021:228–247.
- Al-Kloub MI, A Bed MA, Al Khawaldeh OA, Al Tawarah YM, Froelicher ES. Predictors of non-adherence to follow-up visits and deferasirox chelation therapy among jordanian adolescents with thalassemia major. Pediatr Hematol Oncol. 2014;31(7):624–637. doi:10.3109/08880018.2014.939792.
- Soegiharto NAM. Faktor-faktor yang berhubungan dengan gangguan pertumbuhan pada pasien talasemia mayor. Glob Med Heal Commun. 2021;9(260):110–115.
- Thavorncharoensap M, Torcharus K, Nuchprayoon I, Riewpaiboon A, Indaratna K, Ubol BO. Factors affecting health-related quality of life in Thai children with thalassemia. BMC Blood Disord. 2010;10:1–10. doi:10.1186/1471-2326-10-1.
- Musallam KM, Khoury B, Abi-Habib R, et al. Health-related quality of life in adults with transfusion-independent thalassaemia intermedia compared to regularly transfused thalassaemia major: new insights. Eur J Haematol. 2011;87(1):73–79. doi:10.1111/j.1600-0609.2011.01623.x.
- Wallander JL, Koot HM. Quality of life in children: A critical examination of concepts, approaches, issues, and future directions. Clin Psychol Rev. 2016;45:131–143. doi:10.1016/j.cpr.2015.11.007.
- Leibson T, Koren G. Informed consent in pediatric research. Pediatr Drugs. 2015;17(1):5–11. doi:10.1007/s40272-014-0108-y.
- Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi:10.1097/00005650-198601000-00007.
- Sinuraya RK, Destiani DP, Puspitasari IM, Diantini A. Tingkat Kepatuhan Pengobatan Pasien Hipertensi di Fasilitas Kesehatan Tingkat Pertama di Kota Bandung. Indones J Clin Pharm. 2018;7(2):124–133. doi:10.15416/ijcp.2018.7.2.124.
- Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39(8):800–812. doi:10.1097/00005650-200108000-00006.
- Sitaresmi MN, Indraswari BW, Rozanti NM, Sabilatuttaqiyya Z, Wahab A. Health-related quality of life profile of Indonesian children and its determinants: a community-based study. BMC Pediatr. 2022;22(1):103. doi:10.1186/s12887-022-03161-0.
- Sitaresmi MN, Mostert S, Gundy CM, Sutaryo VA. Health-related quality of life assessment in Indonesian childhood acute lymphoblastic leukemia. Health Qual Life Outcomes. 2008;6:96. doi:10.1186/1477-7525-6-96.
- Putranto KA, Salimo H, Riza M. Perbedaan kualitas hidup pada remaja talasemia mayor dengan gizi kurang dan gizi baik menggunakan instrumen PedsQL. SP. 2021;23(3):171–177. doi:10.14238/sp23.3.2021.171-7.
- Alshamsi S, Hamidi S, Narci H. Health-related quality of life and associated factors of children with transfusion-dependent Thalassemia in Dubai, United Arab Emirates. GJHS. 2021;13(7):18. doi:10.5539/gjhs.v13n7p18.
- Mettananda S, Pathiraja H, Peiris R, et al. Health related quality of life among children with transfusion dependent β-thalassaemia major and haemoglobin E β-thalassaemia in Sri Lanka: A case control study. Health Qual Life Outcomes. 2019;17(1):1–13. doi:10.1186/s12955-019-1207-9.
- Boonchooduang N, Louthrenoo O, Choeyprasert W, Charoenkwan P. Health-related quality of life in adolescents with Thalassemia. Pediatr Hematol Oncol. 2015;32(5):341–348. doi:10.3109/08880018.2015.1033795.
- Nugraha D, Silman C, Aryudi C, et al. Faktor–faktor yang berhubungan dengan kualitas hidup pasien thalassemia mayor di pusat thalassemia departemen ilmu kesehatan anak RSCM. SP. 2016;11(2):85–89. doi:10.14238/sp11.2.2009.85-9.
- Ansari S, Baghersalimi A, Azarkeivan A, Nojomi M, Hassanzadeh RA. Quality of life in patients with thalassemia major. Iran J Pediatr Hematol Oncol. 2014;4(2):57–63.
- Michel G, Bisegger C, Fuhr DC, Abel T. Age and gender differences in health-related quality of life of children and adolescents in Europe: a multilevel analysis. Qual Life Res an Int J Qual Life Asp Treat Care Rehabil. 2009;18(9):1147–1157. doi:10.1007/s11136-009-9538-3.
- Quittkat HL, Hartmann AS, Düsing R, Buhlmann U, Vocks S. Body dissatisfaction, importance of appearance, and body appreciation in men and women over the lifespan. Front Psychiatry. 2019;10:978–983. doi:10.3389/fpsyt.2019.00864.
- Chordiya K, Katewa V, Sharma P, Deopa B, Katewa S. Quality of life (QoL) and the factors affecting it in transfusion-dependent thalassemic children. Indian J Pediatr. 2018;85(11):978–983. doi:10.1007/s12098-018-2697-x.
- Beer SS, Juarez MD, Vega MW, Canada NL. Pediatric malnutrition: Putting the new definition and standards into practice. Nutr Clin Pract off Publ Am Soc Parenter Enter Nutr. 2015;30(5):609–624. doi:10.1177/0884533615600423.
- Bhosale M, Chandanwale A, Kinikar A, Singh D, Chaudhary R. Impact of splenectomy on quality of life of children with β-thalassemia. Int J Med Public Health. 2015;5(4):322. doi:10.4103/2230-8598.165963.
- Sidhu S, Kakkar S, Dewan P, Bansal N, Sobti PC. Adherence to iron chelation therapy and its determinants. Int J Hematol Oncol Stem Cell Res. 2021;15(1):27–34. doi:10.18502/ijhoscr.v15i1.5247.
- Locke M, Reddy PS, Badawy SM. Adherence to iron chelation therapy among adults with Thalassemia: A systematic review. Hemoglobin. 2022;46(4):201–213. doi:10.1080/03630269.2022.2072320.
- Reddy PS, Locke M, Badawy SM. A systematic review of adherence to iron chelation therapy among children and adolescents with thalassemia. Ann Med. 2022;54(1):326–342. doi:10.1080/07853890.2022.2028894.
- Badawy SM, Morrone K, Thompson A, Palermo TM. Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia. Cochrane Database Syst Rev. 2019;6(6):CD012900. doi:10.1002/14651858.CD012900.pub2.